Abstract:Background: Patients with coronary artery disease (CAD) have impaired endothelial function. Simvastatin therapy has been demonstrated to significantly improve endothelial function in these patients. Although withdrawal of statins is a frequent problem in clinical practice, the effects after discontinuation of statins treatment on endothelial function in patients with CAD are largely unknown.Objective: This study investigated the effects after withdrawal of simvastatin on brachial artery endothelial function in patients with CAD and the underlying mechanisms.Methods: We recruited 30 patients with established CAD. They were treated with 20 mg simvastatin for 4 weeks. Endothelial dependent flow-mediated vasodilation (FMD) was assessed in the brachial artery using high-resolution ultrasound at baseline, 4 weeks during simvastatin treatment, and 1 week after termination of therapy. 20 healthy subjects were also studied as a control group. Furthermore, we investigated underlying mechanisms on human umbilical vein endothelial cells (HUVECs) confluent monolayers at passages 2-3. HUVECs were exposed to simvastatin. After 24 h cells were repeatedly washed to remove the drugs, and the conditioned mediums were collected at the indicated time points. The nitric oxide (NO) production and levels of eNOS mRNA after 24 h of withdrawal of statins were examined.Results: (1) Abrupt discontinuation of simvastatin treatment leads to a rebound of serum total cholesterol (21.3%) and LDL cholesterol (18.2%) in patients within 1 week, but they were still lower than the baseline values (P<0.05 for each parameter). (2) A significant decreased of FMD (-59.3%) was observed in patients after discontinuation of simvastatin in 1 week, and furthermore, the FMD was even lower than the baseline levels (4.6% vs. 5.6%, P<0.05). The reduction of FMD was not correlated with the change of LDL cholesterol (r=-0.343, P=0.081). In contrast to the unchanged LDL cholesterol level, abrupt discontinuation of therapy caused a rapid and significant decrease in FMD from 10.6% to 5.2% in healthy subjects at day 1, but it returned to baseline levels within 1 week. (3) In HUVECs, a maximum decrease of nitrite levels (-80%) was observed at 6 h after stopping simvastatin treatment, which was below the control levels. 24 h after stopping 10(-5) mmol/L and 10(-6) mmol/L simvastatin treatment, eNOS mRNA expression decreased to - 71% and - 42% (P<0.05), respectively.Conclusions: Abrupt withdrawal of simvastatin treatment not only acutely and completely abrogates its beneficial effects on endothelial function in patients with CAD, but also induced further vascular injury compared with pretreatment status, independent of cholesterol levels. The underlying mechanism of these negative effects may be related to the suppression of endothelial NO production, which are dose-dependent. (C) 2008 Published by Elsevier Ireland Ltd.

Effects of statin withdrawal on brachial artery endothelial function in patients with major surgery

Statin Withdrawal Beyond Acute Phase Affected Outcome of Thrombolytic Stroke Patients

[The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].

Effect of atorvastatin on decreasing a hypertensive response to exercise and improving exercise tolerance

Effect of statin on improves cardiac diastolic function and reduces exercise B-type natriuretic peptide level

Effect of Lipitor on the Biomechanics of Carotid Atherosclerotic Plaques by Velocity Vecto Imaging

The effects of simvastatin withdrawal on brachial artery endothelial function in healthy normocholesterolemic men]

Influence of atorvastatin on ion pump activity of smooth muscle cells and intima proliferation after arterial intimal injury

Effect of atorvastatin on exercise tolerance in patients with diastolic dysfunction and exercise-induced hypertension

[Effects of Withdrawal of Statins on Nitric Oxide Production in Vascular Endothelial Cells].

Short-Term Withdrawal of Simvastatin Induces Endothelial Dysfunction in Patients with Coronary Artery Disease: A Dose-Response Effect Dependent on Endothelial Nitric Oxide Synthase

The Effect and Underlying Mechanism of Statins in the Prevention of Post-Contrast Acute Kidney Injury: A Multicenter Retrospective Observational Study

Effect of Statin Treatment on Vasospasm-Related Morbidity and Functional Outcome in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis

[Effects of Atorvastatin on Endothelium Protection in Spontaneously Hypertensive Rats].

The Effect of Atorvastatin on Lowering Lipids in Elderly Patients with Type 2 Diabetic Mellitus Plus Hyperlipidemia

Atorvastatin Decreased Low Density Lipoprotein Level and Improved Coronary Artery Lesion in Patients after Percutaneous Coronary Intervention

Effects of Statins on the Liver: Clinical Analysis of Patients with Ischemic Stroke

Effects of Preoperative Short Term Use of Atorvastatin on Endothelial Progenitor Cells after Coronary Surgery: A Randomized, Controlled Trial

Efficacy and Safety of Serial Atorvastatin Load in Chinese Patients Undergoing Elective Percutaneous Coronary Intervention: Results of the ISCAP (intensive Statin Therapy for Chinese Patients with Coronary Artery Disease Undergoing Percutaneous Coronary Intervention) Randomized Controlled Trial

Effects of Atorvastatin Loading Prior to Primary Percutaneous Coronary Intervention on Endothelial Function and Inflammatory Factors in Patients with ST-segment Elevation Myocardial Infarction

Efficacy of High-dose Statins Pretreatment on PCI-related Inflammation and Myocardial Injury